EP1908470A4 - Agent de protection du peritoine - Google Patents

Agent de protection du peritoine

Info

Publication number
EP1908470A4
EP1908470A4 EP06756476A EP06756476A EP1908470A4 EP 1908470 A4 EP1908470 A4 EP 1908470A4 EP 06756476 A EP06756476 A EP 06756476A EP 06756476 A EP06756476 A EP 06756476A EP 1908470 A4 EP1908470 A4 EP 1908470A4
Authority
EP
European Patent Office
Prior art keywords
peritoneum
protecting agent
protecting
agent
peritoneum protecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06756476A
Other languages
German (de)
English (en)
Other versions
EP1908470A1 (fr
Inventor
Takatoshi Kakuta
Toshio Miyata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tokyo Medical and Dental University NUC
Tokai University Educational Systems
Original Assignee
Tokyo Medical and Dental University NUC
Tokai University Educational Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tokyo Medical and Dental University NUC, Tokai University Educational Systems filed Critical Tokyo Medical and Dental University NUC
Publication of EP1908470A1 publication Critical patent/EP1908470A1/fr
Publication of EP1908470A4 publication Critical patent/EP1908470A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4415—Pyridoxine, i.e. Vitamin B6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
EP06756476A 2005-05-24 2006-05-23 Agent de protection du peritoine Withdrawn EP1908470A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005150887 2005-05-24
PCT/JP2006/310220 WO2006126523A1 (fr) 2005-05-24 2006-05-23 Agent de protection du peritoine

Publications (2)

Publication Number Publication Date
EP1908470A1 EP1908470A1 (fr) 2008-04-09
EP1908470A4 true EP1908470A4 (fr) 2009-06-24

Family

ID=37451948

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06756476A Withdrawn EP1908470A4 (fr) 2005-05-24 2006-05-23 Agent de protection du peritoine

Country Status (8)

Country Link
US (2) US20090030047A1 (fr)
EP (1) EP1908470A4 (fr)
JP (1) JPWO2006126523A1 (fr)
KR (1) KR20080034845A (fr)
CN (1) CN101227904A (fr)
AU (1) AU2006250547A1 (fr)
CA (1) CA2624090A1 (fr)
WO (1) WO2006126523A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5128003B2 (ja) * 2010-07-23 2013-01-23 学校法人東海大学 腹膜透析患者用の経口医薬組成物及びその用法
US20160063087A1 (en) * 2013-05-17 2016-03-03 Kevin Berson Method and system for providing location scouting information

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017995A1 (en) * 1995-09-12 2003-01-23 Kansas University Medical Center Dialysis solutions and methods

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228858B1 (en) * 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US5717976A (en) * 1995-08-28 1998-02-10 Eastman Kodak Company Stack of sheets and method of assuring orientation
US6740668B1 (en) * 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US5744451A (en) * 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
JPH10324629A (ja) * 1997-03-28 1998-12-08 Otsuka Pharmaceut Co Ltd Ａｇｅ生成阻害組成物
AU8898898A (en) * 1997-08-07 1999-03-01 Ajay Gupta Dialysis solutions containing water soluble vitamins and nutrients
EP1108434B1 (fr) * 1998-08-24 2014-05-14 Kurokawa, Kiyoshi Medicaments de sedation de l'agression du carbonyle et des dialysats peritoneaux
EP1121121B1 (fr) * 1998-10-22 2003-06-04 University Of South Carolina Procedes pour inhiber les complications diabetiques
JP2004300153A (ja) * 2003-03-20 2004-10-28 Kiyoshi Kurokawa 蛋白修飾物生成抑制剤
WO2005018649A1 (fr) * 2003-08-25 2005-03-03 Nagoya Industrial Science Research Institute Agent permettant d'inhiber la formation d'un produit final de saccharification
WO2005077902A2 (fr) * 2004-02-09 2005-08-25 Biostratum, Inc. Methodes de synthese de pyridoxamine

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030017995A1 (en) * 1995-09-12 2003-01-23 Kansas University Medical Center Dialysis solutions and methods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KAKUTA TAKATOSHI ET AL: "Pyridoxamine improves functional, structural, and biochemical alterations of peritoneal membranes in uremic peritoneal dialysis rats", KIDNEY INTERNATIONAL, vol. 68, no. 3, September 2005 (2005-09-01), pages 1326 - 1336, XP002523416, ISSN: 0085-2538 *
NAKAMURA SAKURAKO ET AL: "Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage", JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, vol. 16, no. 1, January 2005 (2005-01-01), pages 144 - 150, XP002523417, ISSN: 1046-6673 *

Also Published As

Publication number Publication date
JPWO2006126523A1 (ja) 2008-12-25
US20110021579A1 (en) 2011-01-27
AU2006250547A1 (en) 2006-11-30
KR20080034845A (ko) 2008-04-22
US20090030047A1 (en) 2009-01-29
EP1908470A1 (fr) 2008-04-09
CA2624090A1 (fr) 2006-11-30
WO2006126523A1 (fr) 2006-11-30
CN101227904A (zh) 2008-07-23

Similar Documents

Publication Publication Date Title
PL2175273T3 (pl) Środek nadający kokumi
EP1950309A4 (fr) Agent de denaturation de l'albumine
ZA200800063B (en) Restraining
LT1811990T (lt) Priemonė prieš demodikozę
GB2444619B (en) Opening protection
GB0604784D0 (en) Integrity protection
EP1927347A4 (fr) Agent réducteur d'amertume
EP2062892A4 (fr) Agent améliorant l'hypertension
EP1889660A4 (fr) Agent de decomposition de l'ozone
EP1867699A4 (fr) Agent de prevention de la deterioration
GB0511590D0 (en) Anti-thrombotic agents
EP2030629A4 (fr) Agent d'amélioration du métabolisme des lipides
GB0603513D0 (en) Protecting sleepsuit
EP2047856A4 (fr) Agent de prévention d'une infection
EP2060263A4 (fr) Agent d'amélioration du métabolisme lipidique
EP1908470A4 (fr) Agent de protection du peritoine
EP1865313A4 (fr) Agent de separation d isomeres optiques
GB2426283B (en) Restraining mechanisms
ZA200803615B (en) Agent for protecting body cells
GB0710882D0 (en) Protection arrangement
TWM291540U (en) Protection film
GB0400310D0 (en) Anti-incrustation agent
GB2431768B (en) Protective case
GB0517792D0 (en) Instrument protection
GB0510744D0 (en) Location checker

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20071220

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090525

17Q First examination report despatched

Effective date: 20090921

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110524